IN8bio, Inc. (INAB) stock

INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$0.82−0.00 (-0.04%)

Close on Nov 13, 2026Market cap $8.08MP/E –Yield –

IN8bio gross margin

Gross margin is gross profit as a percentage of revenue.

IN8bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?